Referral for evaluation for metabolic and bariatric surgery may be appropriate for patients with BMI 35 kg/m with obesity-related complications or BMI 40 kg/m who have not responded adequately to pharmacotherapy, though insurance criteria may vary
If that happens, you can risk becoming malnourished or, if you dont drink enough water, dehydrated
Clinical trials of tirzepatide show that gastrointestinal side effectsincluding nausea, vomiting, and burpingoccur in 2550% of patients, with severity typically highest in the first 48 weeks
The high cost of GLP-1 plus the risk of inappropriate or unnecessary prescriptions requires GLP-1 coverage to be a structured process with checks and balances to ensure necessary and effective prescribing and avoid side effects that can result in early discontinuation
Suppliers have taken advantage of the willingness of branded pharma companies (especially GLP-1s) to pay above market pricing for these items, whereas manufacturers of generic parenteral products cannot absorb these costs
Food & Drug Administration (FDA) for general medical use